MedPath

Evaluation of cardiac risk in rheumatoid arthritis patients befoer and after treatment of Biologics in retrospective study

Not Applicable
Conditions
rheumatoid arthiritis
Registration Number
JPRN-UMIN000013885
Lead Sponsor
Itabashi Chuo Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria were diabetes, previous cardiovascular events, cardiopathy, hypertension and renal disease.

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of NT-pro BNP after treatment at 24 weeks of Biologics.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath